Sy, Eduardo C.
HRN: 21-46-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
CEFTRIAXONE 1G (VIAL)
06/14/2022
06/22/2022
IVT
1g
Q12
Infected Wound L Foot
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes